Literature DB >> 6786991

Female sex steroid receptor status in primary and metastatic breast carcinoma and its relationship to serum steroid peptide hormone levels.

R Vihko, O Jänne, K Kontula, P Syrjälä.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1980        PMID： 6786991     DOI： 10.1002/ijc.2910260104

Source DB:  PubMed          Journal:  Int J Cancer        ISSN： 0020-7136            Impact factor:   7.396


× No keyword cloud information.
  16 in total

1.  Immunohistochemical versus biochemical estrogen-receptor and progesterone-receptor analysis: correlation with histological parameters.

Authors:  M Helle; M Helin; J Isola; H Helin
Journal:  J Cancer Res Clin Oncol       Date:  1989       Impact factor: 4.553

2.  Influence of endocrine status on biochemical and immunocytochemical estrogen and progesterone receptor assays in breast cancer patients.

Authors:  H J Helin; J J Isola; M J Helle; H Adlercreutz
Journal:  Breast Cancer Res Treat       Date:  1988-09       Impact factor: 4.872

3.  The important prognostic value of Ki-67 expression as determined by image analysis in breast cancer.

Authors:  T Pietiläinen; P Lipponen; S Aaltomaa; M Eskelinen; V M Kosma; K Syrjänen
Journal:  J Cancer Res Clin Oncol       Date:  1996       Impact factor: 4.553

4.  Estrogen receptor alpha-negative and progesterone receptor-positive breast cancer: lab error or real entity?

Authors:  Jawad Kiani; Afrasyab Khan; Hina Khawar; Fawad Shuaib; Shahid Pervez
Journal:  Pathol Oncol Res       Date:  2006-12-25       Impact factor: 3.201

5.  Hyaluronan in peritumoral stroma and malignant cells associates with breast cancer spreading and predicts survival.

Authors:  P Auvinen; R Tammi; J Parkkinen; M Tammi; U Agren; R Johansson; P Hirvikoski; M Eskelinen; V M Kosma
Journal:  Am J Pathol       Date:  2000-02       Impact factor: 4.307

6.  Tumour vascularity and basement membrane structure in breast cancer as related to tumour histology and prognosis.

Authors:  P Lipponen; H Ji; S Aaltomaa; K Syrjänen
Journal:  J Cancer Res Clin Oncol       Date:  1994       Impact factor: 4.553

7.  Nandrolone decanoate added to tamoxifen in the treatment of advanced breast cancer.

Authors:  E Heinonen; A Alanko; P Gröhn; P Rissanen
Journal:  Breast Cancer Res Treat       Date:  1985       Impact factor: 4.872

8.  Proliferating-cell nuclear antigen (PC10) immunolabelling and other proliferation indices as prognostic factors in breast cancer.

Authors:  S Aaltomaa; P Lipponen; S Papinaho; K Syrjänen
Journal:  J Cancer Res Clin Oncol       Date:  1993       Impact factor: 4.553

Review 9.  The predictive value of steroid hormone receptor analysis in breast, endometrial and ovarian cancer.

Authors:  R Vihko; A Alanko; V Isomaa; A Kauppila
Journal:  Med Oncol Tumor Pharmacother       Date:  1986

10.  Estrogen receptors in mammary cancer: correlation with age, menopausal status, and response to therapy.

Authors:  R Johansson; R Vanharanta; J Söderholm
Journal:  J Cancer Res Clin Oncol       Date:  1984       Impact factor: 4.553
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.